Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies
The DOI matches its Crossref record.
Abstract
The endocannabinoid system, consisting of cannabinoid1 (CB1) and cannabinoid2 (CB2) receptors, endogenous cannabinoid ligands and metabolising enzymes, is present throughout the pathways mediating responses to painful stimuli. Electrophysiological and behavioural studies have demonstrated that endocannabinoids, as well as plant-derived and synthetic cannabinoid agonists have anti-nociceptive effects in animal models of acute, inflammatory and neuropathic pain. CB1 receptors located at peripheral, spinal and supra-spinal sites are an important target mediating the antinociceptive effects of cannabinoid agonists. Recent evidence points to an additional role of CB2 receptors, particularly during inflammatory and neuropathic pain conditions. The mechanisms underlying the analgesic effects of cannabinoids are likely to involve inhibition of pre-synaptic neurotransmitter and neuropeptide release in addition to modulation of post-synaptic neuronal excitability. Modulation of pro-nociceptive and pro-inflammatory mediators from immune cells may be another mechanism by which cannabinoids exert their effects in the periphery. Points of convergence between cannabinoids and other classes of analgesic agents including the opioids and cyclooxygenase inhibitors offer further insight into the potential sites and mechanisms of interactions between these systems. The large body of pre-clinical evidence in support of cannabinoids as potential analgesic agents provides the functional framework for large-scale controlled clinical trials of the effects of cannabinoids and modulation of the endocannabinoid system during painful conditions. Keywords: pain, cannabinoid receptor, endocannabinoids
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The effect of pain on cognitive function: A review of clinical and preclinical research
Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122
Self-citationElmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160
Self-citationElmes, S. J. R., Winyard, L. A., Medhurst, S. J., Clayton, N. M., Wilson, A. W., Kendall, D. A., & Chapman, V. (2005) · Pain · doi:10.1016/j.pain.2005.09.005 · Cited by 97
“The antinociceptive effects of cannabinoid agonists, such as CP55940, WIN55212-2 and HU210, are well described in animal models of acute and inflammatory pain (see refs. in Pertwee, 2001; Finn and Chapman, 2004).”
BackgroundInfluentialSelf-citationRoche, M., O'Connor, E., Diskin, C., & Finn, D. P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05861.x · Cited by 83
“…fear (Marsicano et al., 2002; Chhatwal et al., 2005; Mikics et al., 2006; for recent review, see Chhatwal & Ressler, 2007) and nociception (Calignano et al., 1998; Meng et al., 1998; Strangman et al., 1998; for recent review, see Pertwee, 2001; Finn & Chapman, 2004; Hohmann & Suplita, 2006).”
BackgroundSelf-citationFinn, D. P., Beckett, S. R. G., Richardson, D., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03509.x · Cited by 66
Self-citation
Metadata
- Authors
- Finn, D., & Chapman, V.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-01-01
- Volume
- 2
- Issue
- 1
- Pages
- 75-89
- ISSN
- 1570-159X (ISSN-L)
- OpenAlex
- W2045665521
- Cited by
- 20
- References
- 0
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies. https://app.cochat.ai/papers/10.2174/1570159043476918
- The paper
- Finn, D., & Chapman, V. (2004). Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies. Current Neuropharmacology. https://doi.org/10.2174/1570159043476918
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.